Mcsp torfp no. NIH-ninds-21-02: trushina (medchem) - base exploratory chemistry (alzheimer's disease)
Ended Awarded Last action
- Contract number
- 75N95021F00001
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $607,397
Award facts
- Opportunity
-
- TORFPNIHNINDS2102 Solicitation number
- Contract value 100% obligated
- $607,397.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Mental Health National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Original award | $607,397 |
About this award
This is a delivery order contract awarded by the National Institute of Mental Health (NIMH) to Curia Global Inc., doing business as Amri, a leading contract development and manufacturing organization (CDMO). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and is for exploratory chemistry research related to Alzheimer's disease. The contract has a ceiling value of $607,397.30 and a performance period ending on June 2, 2025. The contract is a cost-plus-fixed-fee type and was not set aside for any specific business category. Curia Global Inc. has a strong track record of supporting federal agencies, particularly within the National Institutes of Health (NIH) ecosystem, with specialized pharmaceutical research and development services across various therapeutic areas.
Quick answers
Who was awarded contract 75N95021F00001?
75N95021F00001 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on February 4, 2021.
How much is contract 75N95021F00001 worth?
The government has obligated $607,397 on 75N95021F00001.
Which agency awarded contract 75N95021F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021F00001, with funding from National Institute of Mental Health (National Institutes of Health).
Is contract 75N95021F00001 an order under another contract?
Yes. 75N95021F00001 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95021F00001 competed?
The extent of competition for 75N95021F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award